XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Valuation of our financial instruments by pricing observability levels as of March 31, 2023 and December 31, 2022 was as follows (in thousands):
 Level 1Level 2Level 3
NAV Expedient(1)
Other Total
March 31, 2023:
Money markets$95,690 $— $— $— $— $95,690 
Securities segregated (U.S. Treasury Bills)— 1,054,638 — — — 1,054,638 
Derivatives 16,683 — — — 16,687 
Investments:
  Equity securities 121,971 28,255 170 1,524 — 151,920 
   Limited partnership hedge funds(2)
— — — — 42,570 42,570 
   Time deposits(3)
— — — — 7,528 7,528 
   Other investments6,894 — — — 3,026 9,920 
Total investments128,865 28,255 170 1,524 53,124 211,938 
Total assets measured at fair value$224,559 $1,099,576 $170 $1,524 $53,124 $1,378,953 
Derivatives4,878 11,533 — — — 16,411 
Contingent payment arrangements— — 248,185 — — 248,185 
Total liabilities measured at fair value$4,878 $11,533 $248,185 $ $ $264,596 
 Level 1Level 2Level 3
NAV Expedient(1)
Other Total
December 31, 2022:
Money markets$95,521 $— $— $— $— $95,521 
Securities segregated (U.S. Treasury Bills)— 1,521,705 — — — 1,521,705 
Derivatives 1,768 22,944 — — — 24,712 
Investments:
  Equity securities129,655 27,799 129 1,484 — 159,067 
    Limited partnership hedge funds(2)
— — — — 42,526 42,526 
    Time deposits(3)
— — — — 7,750 7,750 
    Other investments6,689 — — — 1,486 8,175 
Total investments136,344 27,799 129 1,484 51,762 217,518 
Total assets measured at fair value$233,633 $1,572,448 $129 $1,484 $51,762 $1,859,456 
Derivatives162 13,550 — — — 13,712 
Contingent payment arrangements— — 247,309 — — 247,309 
Total liabilities measured at fair value$162 $13,550 $247,309 $ $ $261,021 

(1) Investments measured at fair value using NAV (or its equivalent) as a practical expedient.
(2) Investments in equity method investees that are not measured at fair value in accordance with GAAP.
(3) Investments carried at amortized cost that are not measured at fair value in accordance with GAAP.
Valuation of consolidated company-sponsored investment funds' financial instruments by pricing observability levels as of March 31, 2023 and December 31, 2022 was as follows (in thousands):
 Level 1Level 2Level 3Total
March 31, 2023:
  Investments - VIEs$125,788 $400,742 $— $526,530 
  Investments - VOEs16,809 — — 16,809 
  Derivatives - VIEs1,211 2,459 — 3,670 
Total assets measured at fair value$143,808 $403,201 $ $547,009 
Derivatives - VIEs14,830 1,481 — 16,311 
Total liabilities measured at fair value$14,830 $1,481 $ $16,311 
December 31, 2022:
  Investments - VIEs$129,706 $386,830 $— $516,536 
  Derivatives - VIEs1,529 6,023 — 7,552 
Total assets measured at fair value$131,235 $392,853 $ $524,088 
Derivatives - VIEs$14,932 $6,608 $— $21,540 
Total liabilities measured at fair value$14,932 $6,608 $ $21,540 
Schedule of Change in Carrying Value Level 3 Financial Instruments
The change in carrying value associated with Level 3 financial instruments carried at fair value, classified as equity securities, is as follows:
 Three Months Ended March 31,
 20232022
 (in thousands)
Balance as of beginning of period$129 $126 
Purchases— — 
Sales— — 
Realized gains (losses), net— — 
Unrealized gains (losses), net41 (7)
Balance as of end of period$170 $119 
The change in carrying value associated with Level 3 financial instruments carried at fair value within consolidated company-sponsored investment funds was as follows:
 Three Months Ended March 31,
 20232022
 (in thousands)
Balance as of beginning of period$— $3,357 
Deconsolidated funds— (3,351)
Transfers (out)— (6)
Purchases— 248 
Balance as of end of period$ $248 
Schedule of Contingent Payment Arrangements Level 3 Financial Instruments The change in carrying value associated with Level 3 financial instruments carried at fair value, classified as contingent payment arrangements, is as follows:
 Three Months Ended March 31,
 20232022
 (in thousands)
Balance as of beginning of period$247,309 $38,260 
Accretion2,443 838 
Payments(792)— 
Held for sale reclassification(775)— 
Balance as of end of period$248,185 $39,098